Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
Neurocrine Biosciences Inc. (NBIX) is a commercial-stage biotechnology company focused on developing treatments for neurological, endocrine, and psychiatric disorders, trading at a current price of $128.52 as of April 6, 2026, marking a 2.34% decline from the previous close. This analysis outlines key technical levels, recent market context, and potential trading scenarios for NBIX, with no recent earnings data available for the company as of the publication date. The stock is currently trading
Will Neurocrine Biosciences (NBIX) Stock Hit Record Highs | Price at $128.52, Down 2.34% - Community Trade Ideas
NBIX - Stock Analysis
3016 Comments
1512 Likes
1
Celica
Returning User
2 hours ago
If only I checked one more time earlier today.
π 219
Reply
2
Reddington
Influential Reader
5 hours ago
Daily US stock market summaries and expert insights delivered straight to your inbox to keep you informed and prepared for trading decisions. We distill complex market information into clear, actionable takeaways that anyone can understand and apply.
π 150
Reply
3
Willidean
Expert Member
1 day ago
Expert US stock portfolio construction guidance with risk-adjusted return optimization for long-term wealth building. We help you build a diversified portfolio that can weather market volatility while capturing upside potential.
π 13
Reply
4
Darie
Legendary User
1 day ago
This solution is so elegant.
π 198
Reply
5
Mekela
Registered User
2 days ago
This came at the wrong time for me.
π 153
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.